|Articles|January 4, 2018
inVentiv Health/INC Research Becomes Syneos Health
Advertisement
Following the merger between INC Research and inVentiv Health, which created a fully integrated biopharmaceutical solutions organization that combined a CRO and CCO, it has been announced that they have changed their brand identity to Syneos Health, Inc. The new brand will combine commercial and clinical solutions to accelerate customer performance.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
2
Controlled Clinical Trials in Sub-Saharan Africa: A Winning Value Proposition
3
ACT Brief: FDA Approval of Oral Wegovy, 2025’s Most-Read ACT Coverage, and Data Quality as the Foundation for AI
4
ACT Brief: Building a Digital Thread in Life Sciences, CRO Sourcing Decisions and Site Burden, and Lilly’s Oral GLP-1 Phase III Results
5